Transfusion and Apheresis Science

Papers
(The median citation count of Transfusion and Apheresis Science is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Relationship between mutations in severe hemophilia A and risk of inhibitor development: A large single-center study31
Successful use of therapeutic plasma exchange for the management of acute lung transplant rejection secondary to immune checkpoint inhibitor therapy30
Nephrolithiasis in two patients on iron chelation therapy: A case report19
Correlation of blood transfusion to progression-free survival and overall survival in multiple myeloma patients undergoing chemotherapy19
Focus on: Prognostic scores to predict stem cell mobilization19
Therapeutic plasma exchange for neonatal hepatic failure17
Guest editor’s bio15
Apheresis and Covid-1915
Editorial Board14
An overview of apheresis activities in Israel 202214
Real-world evidence on effectiveness and safety of granulocyte transfusion (GT) during pre-engraftment phase in hematopoietic stem cell transplant patients: A single-centre study from north India, wit13
The effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation12
Sex discrepancies in blood donation: Implications for red blood cell characteristics and transfusion efficacy12
The practical use of artificial intelligence in Transfusion Medicine and Apheresis10
A serological and molecular study on a case of Rh blood group mosaicism10
PREDICTIVE ALGORITHM FOR HAEMATOPOIETIC STEM CELL COLLECTION AS A TOOL FOR INTERCONNECTION BETWEEN TRANSPLANT PROGRAM FACILITIES10
Analysis of fresh frozen plasma utilization indications in children: An audit of a tertiary care hospital in Turkey10
Adjuvant lipoprotein apheresis for hyper-Lp(a) in diabetic foot and peripheral artery disease10
Replacement fluids in apheresis10
Are we donating iron? Impact of apheresis on ferritin10
Impact on cytokine accumulation in 35-day preserved whole blood due to resin adsorption9
Transfusion safety: Is there a difference between reported reactions in low-to-middle income and high-income countries?9
Does immunohistochemical staining predict mobilization success in multiple myeloma patients?9
Assessment of the impact of pathogen reduction technologies on the neutralizing activity of COVID-19 convalescent plasma.9
Red Ribbon Club inculcation of positive deviance approach to promote blood donation among undergraduate medical college students9
A rare report of H-partially deficient, non-secretor phenotype from India. An Ah like the rèunion and unlike a Para Bombay-Clarifying misinterpretations.9
MOBILIZATION AND COLLECTION OF AUTOLOGOUS HSCS IN PATIENTS WITH MM IN DARATUMUMAB ERA. EXPERIENCE OF A SINGLE CENTER.8
Intermediate-dose cyclophosphamide and bortezomib for PBSC mobilization in multiple myeloma8
The Polish adaptation of the blood donation fears inventory8
THE NURSE IN THE MANAGEMENT OF ADVERSE EVENTS8
Role of the AB0 blood group in COVID-19 infection and complications: A population-based study8
Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell disease8
Examining participant representation by sex, race, ethnicity and age in United States blood donation and blood transfusion clinical trials8
INTRAOPERATIVE BLOOD RECOVERY FROM THE PATIENT BLOOD MANAGEMENT PERSPECTIVE: THE SERENISSIMA’ EXPERIENCE.8
How to begin using social media for transfusion medicine education8
Yogyakarta and the WAA:20248
Editorial Board8
A CASE OF UNUSUAL TIMING – ON DEMAND PLERIXAFOR USE8
The impact of anticoagulant used for peripheral blood collection on NK cell yield, function, and proliferation7
Association of HLA-DRB1 alleles with anti-D alloimmunization in RhD negative pregnant women in India7
The impact of apheresis on blood clotting components and its effect on clotting mechanisms7
Update on the measurement of "soluble angiotensin converting enzyme 2" in plasma and its emerging significance as a novel biomarker of cardiovascular and kidney diseases: A concise commentary7
Use of therapeutic apheresis methods during pregnancy7
Blood, organ and bone marrow donation: Reporting on the attitudes, related to socio-emotional determinants, among nursing students in Greece7
Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD)7
How to manage poor mobilisers7
Revisiting reference intervals in transfusion medicine: Innovations and challenges in current practice7
Editorial Board6
Blood donors, iron deficiency and supplementation options – Will clinical trials help moving forward?6
Case report of anti-f(ce) antibody identified with unknown autoantibody from ABO discrepancy in a patient with liver cell carcinoma6
Optimizing of the isolation of hematopoietic stem cell in bone marrow transplantation in children6
Plasma exchange in patients with ANCA-associated vasculitis6
Efficiency and safety of granulocyte colony-stimulating factor combined with plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in light chain amyloidosis6
Gynecological bleeding in women with congenital bleeding disorders: A comprehensive cohort from Iran6
Correlation between blood parameters in the early and later stages of pregnancy: A retrospective study6
Guest Editor’s Bio6
Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?6
Editorial Board6
Editorial commentary6
Enhancing clinical insight: Implementing validated questionnaires for comprehensive assessment of clinician expertise in transfusion medicine practices6
Trends in cell collection and apheresis practices: Insights from a cross-sectional study on the use of Spectra Optia in collection and transplant centers6
Apheresis and COVID-19 in intensive care unit (ICU)6
CAR-T cells, the first pharmaceutical cell therapy6
Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years6
Findings in the Immuno-hematology workshop during the International Congress of the WAA 2024 in Indonesia6
People, places and things: The new WAA board5
Connectivity in transfusion medicine: Challenges, benefits, and goals5
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes5
What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?5
ABO group-based strategy for inventory management of methylene blue-treated thawed plasma in a blood bank5
Lipid modification induced by lipoprotein apheresis could mirrored mid-regional-pro-adrenomedullin plasma levels?5
Anti-M induced severe Hemolytic Disease of the Fetus and Newborn: The role of the Monocyte Monolayer Assay in elucidating the clinical relevance of alloantibodies in pregnancy5
Platelet function testing: Update on determinant variables and permissive windows using a platelet-count-based device5
Plasmapheresis can improve clinical outcomes in patients with therapy resistant benign recurrent intrahepatic cholestasis: A case report5
The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise5
What’s happening CAR T cell immunotherapy5
Relapsed Thrombotic Thrombocytopenic Purpura and Daratumumab utility5
Treatment with plasma exchange of a pregnant woman with anti-PP1Pk alloimmunization: A case report5
Expression of biofilm-associated genes in Staphylococcus aureus during storage of platelet concentrates5
Overview on novel strategies and current guidelines for hematopoietic stem cell mobilisation and collection5
Therapeutic apheresis in ANCA Associated Vasculitis: Current status of Pexivas5
Development and validation of a novel orthopedic blood use prediction model incorporating lab tests and thromboelastography5
Granulocyte apheresis in donors: A comparative study of spectra optia and cobe spectra apheresis systems5
Etoposide + cytarabine + pegfilgrastim versus cyclophosphamide + G-CSF for stem cell mobilization in patients with poorly mobilized multiple myeloma and lymphoma5
Comparative study on the effects of saline and lactated ringer's solution as washing solutions for red blood cell transfusions5
New WAA member: The Spanish Apheresis Group5
Hematological toxicities of immune checkpoint inhibitors and the impact of blood transfusion and its microbiome on therapeutic efficacy and recipient’s safety and survival outcome:A systematic narrati5
Platelet and extracellular vesicles in COVID-19 infection and its vaccines5
WITHDRAWN: The risks of low hemoglobin deferral in a large retrospective cohort of plasmapheresis donors and the influence factors of return for a subsequent donation in China5
The blood transfusion service of Ukraine5
An invite for evidence-based insights and expert viewpoints on blood donor recruitment and retention5
Mechanism of TLR4 mediated immune effect in transfusion-induced acute lung injury based on Slit2/Robo4 signaling pathway5
Feasibility of preparing whole blood-derived pooled buffy coat granulocyte concentrates for pediatric patients5
A global gathering for the future of apheresis: The 15th ISFA World Congress and 4th TSFA National Congress in Bangkok, Thailand5
Factors affecting the development of hypokalemia during apheresis in healthy donors5
Disrupted balance: The impact of apheresis on calcium and magnesium metabolism5
Deferral due to low hemoglobin and predictors of permanence in the blood donation system of repeat female blood donors4
International forum: WAA meets in Yogaykarta4
RBC deformability and clinical relevance in transfusion recipients4
Treatment of acute and chronic graft-versus-host disease with extracorporeal photopheresis: Update of best practice recommendations from Italian Society of Hemapheresis and Cell Manipulation (SIdEM) a4
Impact of peri-operative red blood cell transfusions for treatment of anemia on acute rejection in renal transplant recipients4
INACTIVATION OF PLTS: WHERE DO WE STAND?4
Blood donor notification rate in a blood bank in Veracruz, Mexico4
Investigating the production of platelet lysate obtained from low volume Cord Blood Units: Focus on growth factor content and regenerative potential4
Rare anti-AnWj autoantibody in a 75-year-old male: Case report and review of the literature4
Predictors of poor haematopoietic stem cell mobilisation in patients with haematological malignancies at a South African centre4
STEM CELL COLLECTION AFTER DARATUMUMAB – BASED INDUCTION THERAPY IN MULTIPLE MYELOMA PATIENTS: SINGLE-CENTER EXPERIENCE4
Biographies of the guest editors for this issue's theme papers on stem cell mobilization and transplantation from a Turkish perspective4
Serology and molecular genetic analysis of two unrelated individuals with the same novel CisAB blood type4
Biographies of the guest editors for the theme papers on graft-versus-host disease (GVHD)4
Molecular basis of DEL phenotype in the Indian population: Insights from next-generation sequencing analysis of two cases4
Editorial comments: Looking for some innovative diagnostic or developmental research studies that might influence our laboratory and clinical decision-making4
CHARACTERIZATION OF AUTOLOGOUS PLATELET-RICH PLASMA (PRP) WITH CYCLIC VOLTAMMETRY (BIONOTE)4
Effectiveness of hemoperfusion (HP) in hemodialysis (HD) patients with Covid-19 infection4
Considerations on the number of plasma donations per donor per year: Pro4
Immunohematological challenges in COVID infected patients4
The RhCcEe phenotype incompatibility in Chinese and presence of DEL in serologically D–, C/E+ individuals4
SCD: MOBILIZATION AND STEM CELL COLLECTION FOR GENE THERAPY4
A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal 4
Mobilization and collection of CD34 + cells in patients with globin disorders: Providing the starting material to manufacturers of autologous gene therapies4
Transfusion support for patients with sickle cell disease4
Editorial Board4
Considerations on risk mitigating strategies for bacterial contamination of platelet concentrates – The Dutch perspective4
Clinical use of CAR T-cells in treating acute lymphoblastic leukemia4
Nurses perspective of apheresis in SARS-CoV-2 infected patients4
A non-parametric framework for evaluating total analytical error in in vitro diagnostic medical devices in transfusion medicine4
Opportunities to Share Information4
Response to Li et al. regarding plasma exchange in AITL-associated warm autoimmune hemolytic anemia4
Is minimizing iatrogenic blood loss the next frontier in transfusion medicine?4
The actual usefulness of culturing apheresis products in hematopoietic stem cell autotransplants4
Editorial Board4
CD161+ REGULATORY T CELLS: A NOVEL MECHANISM OF ACTION FOR THE GRAFT VERSUS LEUKEMIA EFFECT3
Blood banking in the United Republic of Tanzania3
The role of red cell exchange in the management of malaria in 20243
High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors3
SARS-CoV-2 variants inactivation of plasma units using a riboflavin and ultraviolet light-based photochemical treatment3
In situ and in vitro evaluation of two antiseptics for blood bank based on chlorhexidine gluconate/isopropyl alcohol and povidone-iodine3
A changing donor landscape revealed by 12.5 years of residual risk estimates of TTIs using the NAT-yield/window period model with public health cost rationale for scale-up in India3
Survey of the current status of blood transfusion in remote areas in Japan3
Transforming care: Patient insights on neurology-led peripheral plasma exchange service3
Plasma exchange and COVID 193
Editorial commentary3
Quality control perspectives: Weak signal detection to prevent clinical sensitivity failures in donor screening3
Effects of continuous negative pressure suction combined with autologous platelet-rich gel on the levels of CRP, IL-6, wound healing and length of stay in clients with diabetic foot3
A case of anti-Rh17 (anti-Hro) antibody in D··phenotype, a rare alloimmunization complicating transfusion management3
Detection of anti-B antibodies in a patient with A1B blood group: A case report and literature review3
Lipoprotein apheresis: Current overview and future outlook in clinical practice3
Blood banking: the situation in Ghana3
A new risk predictive scoring system of vasovagal reactions in patients with preoperative autologous blood donation3
Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments3
Prevalence of hemorrhagic ovarian cysts in patients with rare inherited bleeding disorders3
Education in transfusion medicine – What is preferred?3
SIDEM-GITMO ECP BEST PRACTICE: ONLINE VERSUS OFFLINE TECHNOLOGY3
Mechanisms of immune modulation by therapeutic plasma exchange3
Decreased levels of ferritin, mild thrombocytosis, and increased erythropoietin are sequential events among frequent plateletpheresis donors: Implication for a ferritin screen3
Genetic determinants of plasma testosterone in male blood donors are associated with altered red blood cell characteristics and survival in cold storage and after transfusion3
Transfusion outcomes and clinical safety of ABO-nonidentical platelets transfusion: A systematic review and meta-analysis3
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?3
PERFORMANCE EVALUATION OF THE FRESENIUS AMICUS BLUE EXTRACORPOREAL PHOTOPHERESIS SYSTEM IN THE TREATMENT OF PATIENTS AFFECTED BY GVHD.3
Apheresis in Ethiopia: Availability, challenges, and opportunities3
Insight into hazards and control of transfusion-transmitted infections in Egypt: A narrative review3
Alirocumab in lipoprotein apheresis: A synergy for patients with high-Lp(a)3
Determination of optimum levels of binding antibody units (BAU) of new quantitative chemiluminescent immuno-assay (CLIA) in COVID-19 vaccinated volunteer blood donors3
Advancement of blood donor factors in RBC and blood component therapy using modern practices and methodologies: How to make multifactorial clinical decisions amid growing complexity3
Immune-mediated platelet transfusion refractoriness in a severely thrombocytopenic patient with myelodysplastic syndrome successfully treated with romiplostim3
GMP in donor centres3
Role of Thromboelastogram in monitoring the activation of the coagulation pathway and assessing the associated risk factors for hypercoagulable state in transfusion dependent thalassemia patients3
Therapeutic apheresis in renal transplantation: An update3
Mother-newborn ABO group discrepancy caused by a rare BW.17 variant3
Genotype-phenotype analyses of Iranian patients with hemophilia B (Leyden -) and hemophilia B (Leyden +): A single-center study3
Platelet inventory management with demand and supply uncertainty and variable pricing considerations3
The effect of G-CSF used after allogeneic hematopoietic stem cell transplantation on engraftment times and platelet suspension replacement numbers3
The prevalence and pattern of alloimmunization in patients with sickle cell disease in Abuja, Nigeria3
An independent reader system that parallels critical steps of full automation capability for immunohematology testing3
Editorial by Chair of the Scientific Program Committee3
Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma3
The Italian registry of therapeutic apheresis: year of activity 20213
Analysis of apheresis outcomes in a cohort of Chilean patients treated with autologous stem cell transplantation: A single center real-world experience3
Plant-based diets for CKD patients, green- based Mediterranean diet: A green nephrology view3
Use of Therapeutic Apheresis methods in ICU3
Update of data from the world apheresis association (WAA) registry3
LncRNAs as potential biomarkers for platelet storage lesion3
ERYTHROEXCHANGE THERAPY: 7 YEARS OF EXPERIENCE AT SIMT IN GELA3
Blood transfusion in autoimmune rheumatic diseases3
Spotlights on the latest opinions on identification, prevention, and management of newer CoV-2 variants: A roundup appraisal on innovative ideas and designer vaccines for Omicron3
Why do RhD negative pregnant women still become anti-D immunized despite prophylaxis with anti-D immunoglobulin?3
Pediatric transfusion practices beyond critical care: Evidence for the need of standardized guidelines and patient blood management3
The emerging roles of ACKR1/Duffy antigen beyond malaria3
CFNAs of RBCs affect the release of inflammatory factors through the expression of CaMKIV in macrophages3
Blood use and alloimmunization in myelodysplastic syndrome patients: A study of a hospital transfusion experience3
IMMUNOABSORPTION IN HEART TRANSPLANT REJECTION: CASE REPORT3
Blood banking in Thailand 20233
Refractory delayed-onset heparin induced thrombocytopenia (HIT) without thrombosis, treated with intravenous immunoglobulin3
Blood banking: The situation in ROMANIA3
A comparison of cyclophosphamide at different dose levels for stem cell mobilization in multiple myeloma3
Acute hemolytic transfusion reaction following ABO-mismatched platelet transfusion: Two case reports3
Editorial commentary – Perspectives on quality assurance in transfusion medicine, from the bedside to the bench to the bedside: A lesson to be learned from a leading expert on enhancing optimal care o2
The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study2
Alterations in trace elements and cation profiles in transfusion-dependent thalassemia patients2
PREVENTION OF EXOGENOUS MICROBIAL CONTAMINATION OF BLOOD COMPONENTS: DISINFECTION OF THE DONOR'S SKIN AND QUALITY CONTROLS.2
Editorial Board2
Screening of subclinical functional hemoglobin and red blood cell abnormalities among blood donors of Fayoum University Hospital in Egypt: Are RET-He, and IRF useful screening tools?2
Biographies of the guest editors for this issue's theme papers on current platelet transfusion practices around the world2
Analysis and clinical significance of peripheral blood routine changes of platelet donors with ultra-high frequency donation2
D or anti-D!!! Unblocking the dilemma of blocking-D phenomenon using acid elution2
Therapeutic plasma exchange in immune thrombotic thrombocytopenic purpura: A six-year prospective study on clinical efficacy, laboratory trends, and sex-based differences2
Norway: Blood donors and the innovative research and development on some unmet challenges2
They come in threes: Marburg virus, emerging infectious diseases, and the blood supply2
Overcoming challenges in managing a high-risk pregnancy with placenta previa and newly diagnosed Bombay phenotype2
FERROCARBOXYMALTOSE THERAPY: HOW THE METHOD OF ADMINISTRATION AFFECTS THE RESPONSE TO TREATMENT2
Spotlights on the trends in performance assessment of qualitative in vitro diagnostic medical devices in transfusion medicine2
A multivariate analysis of the risk of iron deficiency in plateletpheresis donors based on logistic regression2
Pharmacoeconomic issues in stem cell mobilization2
International forum: The WAA next Congress2
Genotype pattern of factor V and XIII abnormalities in the Iranian population: A meta-analysis2
Evaluation of hematologic factors and bilirubin following exchange transfusion in neonatal hyperbilirubinemia2
The molecular diagnosis and management of rare D--/D-- variants within a family of Iranian descent2
Efficacy of Ruxolitinib in the management of chronic GVHD2
Bacterial contamination of platelets concentrates in a lower middle-income country: Data from a single tertiary care hospital2
Intra-procedure white blood cell monitoring as a predictor of collection efficiency in mononuclear cell apheresis2
Book review2
Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients2
Variable impact of graft CD3+ cell content on graft versus host disease in hematopoietic stem cell transplant recipients: Is the role of donor CD3+ cells overestimated?2
The D-dimer reference intervals in healty term newborns2
Breast milk induced immune haemolytic disease of newborn due to anti-c: A case report2
A case of hyperhemolysis syndrome in sickle cell disease and concomitant COVID-192
Novel approaches for hematopoietic stem cell mobilisation and collection need to be assessed for qualification and validation to accomplish the proper requirements of their intended purpose2
Utilization of emicizumab in acquired hemophilia A: A case report2
Outcomes in patients with thrombotic microangiopathy associated with a trigger following plasma exchange: A systematic literature review2
A salute to John Verrier Jones: one of the founding fathers of apheresis published in Transfusion Science, vol. 16, 19952
Cerebral and intestinal oxygen saturation of different volumes of red blood cell transfusion in preterm infants2
Impact of therapeutic plasma exchange on intact protein S, apolipoproteins, and thrombin generation2
Editorial Board2
Study on the antigens and antibodies of Mur and Mia blood groups in southern China2
A low dose is better than no dose: Is it time to consider lowering the US minimum plateletpheresis yield?2
When should I use filgrastim after autologous transplantation in MM patients?2
Relapse and beyond: Navigating the long-term clinical impacts of immune thrombotic thrombocytopenic purpura2
Molecular and clinical profile of rare bleeding disorders: A single-center retrospective study2
Comparison of transfusion-outcome in patients with massive bleeding receiving pathogen-reduced platelets prepared with two different technologies2
Comparative performance analysis of artificial intelligence models in therapeutic apheresis training: A pilot study2
Simulation-based medical education in transfusion medicine: Current state and future applications2
The effect of agitating buffy coats on platelet quality before soft spin2
Immunohematological evaluation of red cell alloimmunization and statistical assessment of various adsorption techniques in warm autoimmune hemolytic anemia2
A report from the SIdEM: Italy2
Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series2
Trends of Infectious Disease Markers Among Healthy Blood Donors In Northern India: A Ten Year Study2
Repurposing surplus plasma and expired platelets into useful biotherapies2
A MULTIDISCIPLINARY APPROACH FOR AUTOLOGOUS PBSC LEUKAPHERESIS IN PRESCHOOL AGE PATIENTS WITH SOLID TUMORS2
Quantification of hepatitis C virus in viremic blood donors in Iran: Need to reinforce post-donation follow up2
Insights on trends in the management of metrological analysis of devices in blood and transfusion medicine services: Verification based on their fitness for purpose and suitability for their respectiv2
0.25240397453308